Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect®

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 99-105

  Sluss, Patrick M ^a   Hayes, Frances J ^a   Adams, Judith M ^a   Barnes, Wayne ^b   Williams, Gregg ^b   Frost, Stephen ^b   Ramp, John ^b   Pacenti, David ^b   Lehotay, Denis C ^c   George, Sabu ^c   Ramsay, Carol ^b   Doss, Robert C ^b   Crowley Jr , William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Estradiol; Immunoassay; Mass spectrometry; Measurement; Reference intervals

Indexed keywords

ESTRADIOL; ESTRIOL; ESTRONE;

ACCURACY; ADULT; AGED; ARTICLE; AUTOMATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DYNAMICS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; ISOTOPE DILUTION ASSAY; MALE; MASS SPECTROMETRY; MENSTRUAL CYCLE; NORMAL HUMAN; PERFORMANCE; PHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; ESTRADIOL; ESTRIOL; ESTRONE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; MENSTRUAL CYCLE; SENSITIVITY AND SPECIFICITY;

EID: 37249092560     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.020     Document Type: Article

References (33)

1. Dighe A.S., Moy J.M., Hayes F.J., and Sluss P.M. High-resolution reference ranges for estradiol, luteinizing hormone, and follicle-stimulating hormone in men and women using the AxSYM assay system. Clin Biochem 38 (2005) 175-179
2. Kratz A., Sluss P.M., Januzzi J., and Lewandrowski K.B. Laboratory values of clinical importance. In: Kaspar D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine (2005), McGraw-Hill Medical Publishing Division, New York 2452-2494
3. Hayes F.J., Gill S., and Sluss P.M. Reproductive endocrinology. In: Lewandrowski K.B. (Ed). Clinical Chemistry: Laboratory Management and Clinical Correlations (2002), Lippincott Williams and Williams, Philadelphia 625-638
4. Nelson R.E., Grebe S.K., OKane D.J., and Singh R.J. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 50 (2004) 373-384
5. Stanczyk F.Z., Cho M.M., Endres D.B., Morrison J.L., Patel S., and Paulson R.J. Limitations of direct estradiol and testosterone immunoassay kits. Steroids 68 (2003) 1173-1178
6. Taieb J., Benattar C., Birr A.S., and Lindenbaum A. Limitations of steroid determination by direct immunoassay. Clin Chem 48 (2002) 583-585
7. Thienpont L. Meeting report: first and second estradiol international workshops. Clin Chem 42 (1996) 1122-1124
8. Tummon I., Stemp J., Rose C., et al. Precision and method bias of two assays for oestradiol: consequences for decisions in assisted reproduction. Hum Reprod 14 (1999) 1175-1177
9. Dehennin L. Estradiol-17 beta determined in plasma by gas chromatography-mass spectrometry with selected ion monitoring of mixed silyl ether-perfluoroacyl ester derivatives and use of various stable-isotope-labeled internal standards. Clin Chem 35 (1989) 532-536
10. Siekmann L. Determination of oestradiol-17 in human serum by isotope dilution-mass spectrometry. Definitive methods in clinical chemistry. J Clin Chem Clin Biochem 22 (1984) 551-557
11. Thienpont L.M., and De Leenheer A.P. Efforts by industry toward standardization of serum estradiol-17 beta measurements. Clin Chem 44 (1998) 671-674
12. Wu H., Ramsay C., Ozaeta P., Liu L., and Aboleneen H. Serum estradiol quantified by isotope dilution-gas chromatography/mass spectrometry. Clin Chem 48 (2002) 364-366
13. Zacharia L.C., Dubey R.K., and Jackson E.K. A gas chromatography/mass spectrometry assay to measure estradiol, catecholestradiols, and methoxyestradiols in plasma. Steroids 69 (2004) 255-261
14. England B.G., Parsons G.H., Possley R.M., McConnell D.S., and Midgley A.R. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem 48 (2002) 1584-1586
15. Yang D.T., Owen W.E., Ramsay C.S., Xie H., and Roberts W.L. Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol 122 (2004) 332-337
16. Thienpont L.M., Verhaeghe P.G., Van Brussel K.A., and De Leenheer A.P. Estradiol-17 beta quantified in serum by isotope dilution-gas chromatography-mass spectrometry: reversed-phase C18 high-performance liquid chromatography compared with immuno-affinity chromatography for sample pretreatment. Clin Chem 34 (1988) 2066-2069
17. Tai S.S., and Welch M.J. Development and evaluation of a reference measurement procedure for the determination of estradiol-17beta in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 77 (2005) 6359-6363
18. NCCLS [CLSI]. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS document EP-5A. 1999. Wayne: NCCLS.
19. Kline J., Kinney A., Kelly A., Reuss M.I., and Levin B. Predictors of antral follicle count during the reproductive years. Hum Reprod 20 (2005) 2179-2189
20. Hubl W., Daxenbichler G., Meissner D., and Thiele H.J. An improved solid-phase enzyme and luminescent immunoassay system for steroid hormones and digoxin. Clin Chem 34 (1988) 2521-2523
21. Cummings S.R., Duong T., Kenyon E., Cauley J.A., Whitehead M., and Krueger K.A. Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA 287 (2002) 216-220
22. Guthrie J.R., Taffe J.R., Lehert P., Burger H.G., and Dennerstein L. Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 11 (2004) 315-322
23. Key T.J., Appleby P.N., Reeves G.K., et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95 (2003) 1218-1226
24. Potischman N., Troisi R., Thadhani R., et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomark Prev 14 (2005) 1514-1520
25. Rexrode K.M., Manson J.E., Lee I.M., Ridker P.M., Sluss P.M., Cook N.R., and Buring J.E. Sex hormone concentrations and risk of cardiovascular events in postmenopausal women. Circulation 108 (2003) 1688-1693
26. Buckler HM, Evans CA, Mamtora H, Burger HG, Anderson DC. Gonadotropin, steroid, and inhibin concentrations in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J Clin Endocrinol Metab 1991 Jan;72(1):116-24 1991;72:-24.
27. Buckler H.M., and Anderson D.C. The perimenopausal state and incipient ovarian failure. In: Lobo R.A. (Ed). Treatment of the postmenopausal woman: Basic and clinical aspects (1994), Raven Press, Ltd., New York 11-24
28. Burger HG, Robertson DM, Baksheev L, Collins A, Csemiczky G, Landgren BM. The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopause. Menopause, 2005 May-Jun;12(3):267-74 2005;12:-74.
29. Hall JE. Neuroendocrine physiology of the early and late menopause. Endocrinol Metab Clin North Am, 2004 Dec;33(4):637-59 2004;33:-59.
30. Kim J.B., Barnard G.J., Collins W.P., Kohen F., Lindner H.R., and Eshhar Z. Measurement of plasma estradiol-17 beta by solid-phase chemiluminescence immunoassay. Clin Chem 28 (1982) 1120-1124
31. Randolph Jr. J.F., Sowers M., Bondarenko I.V., Harlow S.D., Luborsky J.L., and Little R.J. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 89 (2004) 1555-1561
32. Rebar R.W. Premature ovarian failure. In: Lobo R.A. (Ed). Treatment of the postmenopausal woman: Basic and clinical aspects (1994), Raven Press, Ltd., New York 25-33
33. Sherman B.M., West J.H., and Korenman S.G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42 (1976) 629-636